ML-007 ER

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameML-007 ER
Drug Alias NameML-007 (MapLight Therapeutics)
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsMuscarinic acetylcholine receptor M1 agonistsMuscarinic acetylcholine receptor M4 agonists
TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M4
Therapy Area/IndicationsSchizophreniaPsychotic DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMapLight Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMapLight Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaPsychotic DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A